TrialRheumatology (Oxford, England)2026

Progression from oligoarticular to polyarticular psoriatic arthritis and apremilast as a disease modifier: Novel insights from FOREMOST.

Laura C Coates et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.